Literature DB >> 6778893

Purification and immunohistochemical localization of relaxin in the human term placenta.

P A Fields, L H Larkin.   

Abstract

Relaxin was purified from human term placentas. A fraction having a molecular weight of approximately 6000 and a specific activity of 11.9 U/mg was eluted from a Bio-Gel P-30 column. This fraction inhibited uterine contractions and produced a linear response to log doses of relaxin in the mouse interpubic ligament bioassay. Electrofocusing of the active Bio-Gel P-30 fraction separated a protein peak with a biological activity of 45 U/mg protein and an isoelectric point of pH 11.4. The electrofocused human relaxin fraction showed cross-reactivity with antiserum produced against highly purified porcine relaxin and formed a single precipitin line with no spurring when compared to purified porcine relaxin in double immunodiffusion assays. Human relaxin was inactivated by the reducing agent dithiothreitol, indicating that disulfide bonds are essential to the biological activity of human placental relaxin. Immunohistochemistry demonstrated that relaxin was located in cells of the basal plate and septae of the placenta.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6778893     DOI: 10.1210/jcem-52-1-79

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  New aspects of placental endocrinology.

Authors:  F Petraglia; L Calzà; G C Garuti; L Giardino; B M De Ramundo; S Angioni
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

2.  Purification and partial characterization of relaxin and relaxin precursors from the hamster placenta.

Authors:  R H Renegar; C R Owens; J M Chalovich
Journal:  Biol Reprod       Date:  1993-07       Impact factor: 4.285

3.  Highly elastic 3D-printed gelatin/HA/placental-extract scaffolds for bone tissue engineering.

Authors:  JiUn Lee; Dongyun Kim; Chul Ho Jang; Geun Hyung Kim
Journal:  Theranostics       Date:  2022-05-13       Impact factor: 11.600

4.  Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants.

Authors:  David Speck; Gunnar Kleinau; Mark Meininghaus; Antje Erbe; Alexandra Einfeldt; Michal Szczepek; Patrick Scheerer; Vera Pütter
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

5.  Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones.

Authors:  P Hudson; M John; R Crawford; J Haralambidis; D Scanlon; J Gorman; G Tregear; J Shine; H Niall
Journal:  EMBO J       Date:  1984-10       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.